CANCER VACCINES WITH EMPHASIS ON A VIRAL ONCOLYSATE MELANOMA VACCINE-Reference-Cited by-同舟云学术

CANCER VACCINES WITH EMPHASIS ON A VIRAL ONCOLYSATE MELANOMA VACCINE

Published:1999-04-01 Issue:1 Volume:46 Page:1-20
ISSN:1217-8950
Container-title:Acta Microbiologica et Immunologica Hungarica
language:
Short-container-title:

Author:

C. Horvath J.¹,Horak Andrea²,G. Sinkovics J.³,Pritchard Mary⁴,Pendleton Stacia⁵,Horvath Elizabeth⁶

Affiliation:

1. 1 St. Joseph.xx.s Hospital Cancer Institute, Department of Medical Microbiology and Immunology Please ask the editor of the journal.

2. 2 St. Joseph.xx.s Hospital Cancer Institute, Department of Medical Microbiology and Immunology Please ask the editor of the journal.

3. 3 St. Joseph.xx.s Hospital Cancer Institute, Department of Medical Microbiology and Immunology Please ask the editor of the journal.

4. 4 St. Joseph.xx.s Hospital Cancer Institute, Department of Medical Microbiology and Immunology Please ask the editor of the journal.

5. 5 St. Joseph.xx.s Hospital Cancer Institute, Department of Medical Microbiology and Immunology Please ask the editor of the journal.

6. 6 St. Joseph.xx.s Hospital Cancer Institute, Department of Medical Microbiology and Immunology Please ask the editor of the journal.

Abstract

Biotherapy of malignant diseases has become the fourth treatment modality besides surgery, chemo- and radiotherapy. Whole cell melanoma vaccines with or without BCG and other adjuvants, purified ganglioside and shed antigens, recombinant viruses carrying tumor antigens, dendritic cells pulsed with antigenic peptides etc.are in clinical trials.Efficacious viral oncolysate vaccines induce the host to mount tumor-specific cytotoxic T-cell response and prevention of relapses is supported by clinical trials. The use of „polyvalent” whole cell vaccines vs. purified or genetically engineered single antigen vaccines is justified asi.only very few single tumor antigens are present in all tumors of a given histological type; andii.antigen modulation occurs in tumors rendering them resistant to immune attack generated by vaccine against a single antigen. Thus polyvalent vaccines immunize against several antigens vs.against a selected antigen.

Publisher

Akademiai Kiado Zrt.

Subject

General Immunology and Microbiology,General Medicine

Link

https://akjournals.com/downloadpdf/journals/030/46/1/article-p1.xml

Reference113 articles.

1. A ten-year follow-up on stage II malignant melanoma patients treated postsurgically with Newcastle disease virus oncolysate.;W. Cassel;Med Oncol Tumor Pharmacother,1993

2. Malignant melanoma. Inflammatory mononuclear cell infiltrates in cerebral metastases during concurrent therapy with viral oncolysates.;W. Cassel;Cancer,1986

3. Identification of human melanoma peptides recognized by Class I restricted tumor infiltrating lymphocytes.;W. Storkus;J Immunol,1993

4. Tumor associated antigens in human renal cell carcinoma: MHC restricted recognition by cytotoxic T lymphocytes.;H. Bernhardt;Tissue Antigens,1996

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monocyte-derived IL-10 Expression Predicts Prognosis of Stage IV Melanoma Patients;Journal of Immunotherapy;2007-11

2. Newcastle disease virus (NDV): brief history of its oncolytic strains;Journal of Clinical Virology;2000-02